SEC Form D · filed April 29, 2016
Eiger BioPharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Nina S. Kjellson · Palo Alto, CADirectorDavid A. Cory · Palo Alto, CAExec · DirectorThomas J. Dietz · Palo Alto, CADirectorJeffrey S. Glenn · Palo Alto, CADirectorEdgar G. Engleman · Redwood City, CADirectorFederico F. Taylor · Dallas, TXDirectorGarry R. Pope · BUFFALO, WYDirectorDan F. Wierck · Austin, TXDirectorJonathan Weiss · ENCINO, CAExec · DirectorJoanne H. Quan · Palo Alto, CAExecCharles J. Bramlage · Palo Alto, CADirectorJames H. Welch · Palo Alto, CAExecJames P. Shaffer · Palo Alto, CAExecEduardo B. Martins · Palo Alto, CAExecJulie Podolec · Dana Point, CADirectorDennis D. Baldwin · Boston, MAExec · DirectorJohn D. Burns · Boston, MADirectorMike S. Sylvestre · Vancouver, British Columbia, CanadaDirectorEdgar G. Engleman · Redwood City, CADirectorJoanne H. Quan · Palo Alto, CAExecCharles J. Bramlage · Palo Alto, CADirectorJames H. Welch · Palo Alto, CAExecJames P. Shaffer · Palo Alto, CAExecEduardo B. Martins · Palo Alto, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗